UK Markets open in 2 hrs 2 mins

GlaxoSmithKline plc (GSK.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
1,506.00+2.00 (+0.13%)
At close: 4:35PM BST
Full screen
Previous close1,504.00
Open1,503.00
Bid1,505.00 x 175400
Ask1,520.00 x 417900
Day's range1,502.50 - 1,512.50
52-week range1,446.50 - 1,745.56
Volume5,347,304
Avg. volume7,594,443
Market cap73.12B
Beta1.15
PE ratio (TTM)44.16
EPS (TTM)34.1
Earnings date25 Oct 2017
Dividend & yield1.01 (5.25%)
Ex-dividend date2017-08-10
1y target est1,743.04
  • Financial Times13 hours ago

    [$$] The questionable strategy of a pharmaceuticals CEO

    Sir, Joining in the discussion about GlaxoSmithKline's new plans, I find chief executive Emma Walmsley's strategic thinking on research and development questionable. I suggest it shows the terrible consequences ...

  • Reuters - UK Focus15 hours ago

    Drugmaker Hikma trims sales forecasts, shares fall

    Hikma Pharmaceuticals Plc (Frankfurt: A0HG69 - news) on Thursday said 2017 revenue would be at the lower end of its forecasts, citing increased pricing pressures in the generic drug industry, sending its shares to a more than three-year low. The company had already cut its full-year guidance in May to the range of $2 billion-$2.1 billion at constant currency from $2.2 billion. "Price erosion by the entire generics industry has been significant," Brian Hoffmann, president of the company's U.S. generics business told Reuters.

  • Fool.co.uk18 hours ago

    Hikma Pharmaceuticals plc’s pain could be GlaxoSmithKline plc’s gain

    Could ongoing approval issues at Hikma Pharmaceuticals plc (LON: HIK) and rivals help GlaxoSmithKline plc (LON:GSK) preserve its dividend?

Yahoo is now part of ‘Oath’ and a member of the Verizon family of companies. As of 15 September 2017, we plan to share some user information within our new family. Learn more